Fareva Paull (Manufacturing, primary packaging; quality control testing (bacterial endotoxins and sterility))

The drug is prescribed to adult patients with HER2-positive metastatic breast cancer or early breast cancer. It is also used to treat HER2-positive gastric or gastroesophageal junction adenocarcinoma.

Dosage form: powder for concentrate for infusion solution

ATC: L01FD01